The efficacy and safety of double (cepeginterferon alfa-2b and ribavirin) and triple (simeprevir, cepeginterferon alfa 2b and ribavirin) treatment regimens in chronic hepatitis C patients. The experience of everyday clinical practice

The efficacy and safety of double (cepeginterferon alfa-2b and ribavirin) and triple (simeprevir, cepeginterferon alfa 2b and ribavirin) treatment regimens in chronic hepatitis C patients. The experience of everyday clinical practice

The objective. To evaluate the efficacy, safety and tolerability of double (cepeginterferon alfa-2b and ribavirin) and triple (simeprevir, cepeginterferon alfa 2b and ribavirin) treatment regimens in chronic hepatitis C patients in everyday clinical practice of the Hepatology Center in Clinical Infe...

Full description

Saved in:
Bibliographic Details
Main Authors: N. P. Blokhina, E. A. Nurmuhametova, M. G. Rusanova, I. V. Gagarina, E. S. Mar’jamova, N. A. Kuznetsova, T. V. Mar’janovskaja, T. V. Lopatina, O. V. Kuzina, I. N. Alekseeva, E. N. Shurenkova, A. V. Devjatkin, Yu. N. Linkova, M. A. Morozova
Format: Article
Language:Russian
Published: Journal Infectology 2016-07-01
Series:Журнал инфектологии
Subjects:
chronic hepatitis c
antiviral therapy
cepeginterferon alfa 2b
simeprevir
Online Access:https://journal.niidi.ru/jofin/article/view/478
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journal.niidi.ru/jofin/article/view/478

Similar Items